Squarepoint
MRK icon

Squarepoint’s Merck MRK Stock Holding History

Squarepoint’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$58.4M Sell
485,900
-56,600
-10% -$6.53M 0.07% 289
2025
Q4 		$57.1M Buy
542,500
+200,400
+59% +$18.8M 0.06% 363
2025
Q3 		$28.7M Sell
342,100
-701,200
-67% -$57.8M 0.03% 590
2025
Q2 		$82.6M Buy
1,043,300
+417,400
+67% +$33.2M 0.09% 257
2025
Q1 		$56.2M Buy
625,900
+322,400
+106% +$30.1M 0.07% 314
2024
Q4 		$30.2M Buy
303,500
+159,900
+111% +$16.5M 0.03% 571
2024
Q3 		$16.3M Buy
143,600
+1,700
+1% +$202K 0.03% 691
2024
Q2 		$17.6M Sell
141,900
-783,400
-85% -$101M 0.03% 650
2024
Q1 		$122M Buy
925,300
+813,800
+730% +$100M 0.21% 67
2023
Q4 		$12.2M Sell
111,500
-44,100
-28% -$4.58M 0.02% 825
2023
Q3 		$16M Buy
155,600
+102,500
+193% +$11M 0.04% 556
2023
Q2 		$6.13M Buy
+53,100
New +$6.03M 0.02% 963
2023
Q1 		– Sell
-35,300
Closed -$3.92M – 3575
2022
Q4 		$3.92M Sell
35,300
-16,800
-32% -$1.72M 0.02% 963
2022
Q3 		$4.49M Sell
52,100
-149,400
-74% -$13.3M 0.02% 825
2022
Q2 		$18.4M Sell
201,500
-71,300
-26% -$6.32M 0.1% 216
2022
Q1 		$22.4M Buy
272,800
+262,500
+2,549% +$20.7M 0.1% 212
2021
Q4 		$789K Buy
10,300
+4,600
+81% +$366K ﹤0.01% 1851
2021
Q3 		$428K Buy
5,700
+2,500
+78% +$190K ﹤0.01% 2053
2021
Q2 		$249K Sell
3,200
-6,022
-65% -$448K ﹤0.01% 2661
2021
Q1 		$678K Buy
9,222
+1,676
+22% +$124K ﹤0.01% 1802
2020
Q4 		$589K Buy
7,546
+4,088
+118% +$313K ﹤0.01% 1694
2020
Q3 		$274K Buy
3,458
+628
+22% +$49.2K ﹤0.01% 1867
2020
Q2 		$209K Buy
+2,830
New +$213K ﹤0.01% 1808
2020
Q1 		– Sell
-5,030
Closed -$437K – 2277
2019
Q4 		$437K Buy
+5,030
New +$413K ﹤0.01% 1845

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Squarepoint's MRK Position: Q1 2026 in Review

Squarepoint increased its Merck (MRK) stake by 1,156% in Q1 2026, buying an estimated $88.3M and bringing the position to 830,857 shares worth $99.9M. The position accounts for 0.12% of the portfolio, ranked #165.

Squarepoint first reported a position in MRK in Q4 2014 and has held it in 37 quarters since. The position peaked at $348M in Q1 2025. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Squarepoint held 830,857 shares of Merck worth $99.9M as of Q1 2026.
  • Squarepoint bought 764,712 Merck shares in Q1 2026, an estimated $88.3M.
  • Merck made up 0.12% of Squarepoint's portfolio in Q1 2026, its #165 holding.
  • Squarepoint first reported a position in Merck in Q4 2014 and has held it in 37 quarters since.
  • Squarepoint's Merck position peaked at $348M in Q1 2025.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Squarepoint's 13F filing for Q1 2026, filed 15 May 2026.